Tag: COVID-19
COVID-19: Eight states contribute to 85% of active caseload, 87% death...
In a high-level meeting to review current status and containment measures of COVID-19, it was revealed that presently eight States (Maharashtra, Tamil Nadu, Delhi, Telangana, Gujarat, Uttar Pradesh, Andhra Pradesh and West Bengal) contribute 85.5% of active caseload and 87% of total deaths in India.....................
Pharma industry set to undego digital transformation, reveals latest survey
Nearly 35% of the operations of the pharma companies need to be shifted digital, according to the survey of C Com Digital on COVID-19 impact. The study also saw that pharmaceutical companies are considering dedicating about 5% to 10% of their marketing budget towards creating webinars and online communications.....................
JNCASR kicks off crash course in molecular diagnosis of infectious diseases...
The course is designed to impart theoretical knowledge as well as hands-on training. Only simulated samples, not containing an infectious virus, have been used for training..................
NBRIC elated as J Mitra’s indigenous COVID-19 antibody test kit gets...
The serology-based total antibody (IgM, IgG, IgA) detection assay is based on the Double Sandwich ELISA principle. The kit was developed with a significant contribution from the International Centre for Genetic Engineering & Biotechnology (ICGEB)..............
India’s 1st 5 day long ‘Virtual Healthcare & Hygiene EXPO 2020’...
This is the first-ever largest virtual exhibition in India marks a new beginning, paving the way for a new norm, wherein a business will happen virtually....................
COVID-19: Abbott begins supply of IgG based antibody tests to India
Abbott's SARS-CoV-2 IgG test can be used for large-scale antibody testing, in line with the ICMR recommendation for the use of IgG CLIA (Chemiluminescence immunoassay) tests. It has demonstrated reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days or more after symptoms started...................
COVID-19: Experts call for increased mHealth consultations in remote areas
In their latest policy brief, the George Institute for Global Health India has summarized barriers and enablers on the use of m-health for delivering primary health care services by health workers in the context of COVID-19.................
COVID-19: Researchers at CSIR-IICB explore neuro-invasive potential of SARS-CoV-2
SERB supported study shows that the collapse of the respiratory center in the brain may cause the breakdown of COVID-19 patients..............
India’s first mobile COVID-19 diagnostic unit, I-Lab created in record 8...
This mobile testing facility that has biosafety facility and is capable of performing RT-PCR as well as ELISA tests, will be deployed through the DBT testing hubs to remote regions of the country.....................
CSIR-CDRI’s COVID-19 drug candidate Umifenovir secures DCGI approval for phase III...
This drug has a good safety profile and acts by preventing the entry of virus into human cells and also by priming the immune system......................






























































